Abaxis said it bought QCR & Trio Diagnostics, its distribution partner for veterinary products in the U.K. and Ireland.
The deal closed on Nov. 17, Abaxis said. Financial terms were not disclosed.
“Over the years QCR & Trio Diagnostics has been a trusted partner and it made strategic sense to integrate them directly into the Abaxis team to drive even greater efficiencies in extending our brand into the veterinary market in Europe,” CEO Clint Severson said in a statement.
“Our goal is to build and strengthen our presence in additional geographic markets to expand the growth potential of Abaxis into the future. Investing more in Europe, and other international markets, will be a focus going forward,” Severson added.
In October, Abaxis said it entered into a U.S. distribution deal for its veterinary products with Henry Schein (NSDQ:HSIC).